The news: Oxford University and AstraZeneca have reported that their covid-19 vaccine is up to 90% effective, according to interim data from the phase 3 trial. The trial found that the vaccine was 70% effective when the data from two different dosing regimes was combined. The first regime, which was 90% effective, used a halved…